期刊文献+

成骨不全COL1A1基因无义突变一例报告

Nonsense mutation of COL1A1 gene in osteogenesis imperfecta:a case report
下载PDF
导出
摘要 成骨不全症是一种遗传性疾病,主要特征为骨量低、骨脆性增加以及损害其他系统表现出骨折、骨骼畸形、身材矮小、蓝巩膜、牙本质发育不全等。本文报告1例成骨不全症患者的病史;对其外周血基因采用全序列外显子基因工程检测信息技术,检测相关致病基因,结果在患者COL1A1基因17号染色体(Chr17:50191826)编码区发现杂合变异:NM_000088.4:exon31:c.2089C>T(p.Arg697^(*))。 Osteogenesis imperfecta is a genetic disorder characterized by low bone mass,increased bone fragility,and skeletal deformities,short stature,blue sclera,and dentin hypoplasia.In this paper,we reported the medical history of a patient with osteogenesis imperfecta and tested genomic DNA for relevant causative genes using a full-sequence exonic genetic engineering test information technology.The results revealed a heterozygous variant in the coding region of chromosome 17(Chr17:50191826)of the patient's COL1A1 gene:NM_000088.4:exon31:c.2089C>T(p.Arg697^(*)).
作者 夏珊 杨艳 曹旭 朱颖 杨毅 张磊 周卉 XIA Shan;YANG Yan;CAO Xu;ZHU Ying;YANG Yi;ZHANG Lei;ZHOU Hui(Zunyi Medical University,Zunyi 563000,Guizhou,China;Department of Endocrinology,Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital,Chengdu 610072,China)
出处 《中华骨质疏松和骨矿盐疾病杂志》 CSCD 北大核心 2022年第5期523-528,共6页 Chinese Journal Of Osteoporosis And Bone Mineral Research
基金 四川省科技计划项目(2020YFS0422)。
关键词 成骨不全症 COL1A1基因 致病性基因 osteogenesis imperfecta COL1A1 gene pathogenic gene
  • 相关文献

参考文献9

二级参考文献68

  • 1艾阳,唐佳,方群,吴晓昀,郭奕斌.一例成骨不全Ⅱ型高危胎儿的产前基因诊断[J].中华临床医师杂志(电子版),2011,5(22):6662-6666. 被引量:5
  • 2胡勇,谢辉,徐荣明,阮永平.浮肩损伤的手术治疗策略[J].中华创伤杂志,2006,22(3):167-170. 被引量:20
  • 3叶志球,郭庆禄,冯长征,魏北阳,刘永熙,张嫣.先天性成骨不全的影像学诊断[J].实用临床医学(江西),2007,8(5):99-101. 被引量:3
  • 4吴晓林,顾鸣敏,崔斌,李西华,袁文涛,陆振虞,宋怀东,王铸钢.一例Ⅰ型成骨不全家系的基因定位及突变检测[J].上海交通大学学报(医学版),2007,27(6):699-702. 被引量:12
  • 5Nguyen ND,Eisman JA, Nguyen TV. Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials. J Bone Miner Res, 2006,21 ( 2 ) : 340 -349.
  • 6Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med, 2007,356 : 1809-1822.
  • 7Siris ES, Harris ST, Rosen C J, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc,2006,81 : 1013-1022.
  • 8Reid IR, Gamble GD, Mesenbrink P, et al. Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab,2010,95:4380-4387.
  • 9Strampel W, Emkey R, Civitelli R. Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf,2007,30:755-763.
  • 10Roelofs AJ, Jauhiainen M, Monkkonen H, et al. Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. Br J Haemato1,2009 ,144 :245-250.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部